))
Season 2 - Ep. 5: LAA occlusion - Chronic thromboembolic pulmonary hypertension
Manage episode 407315172 series 3559418
Contenu fourni par European Society of Cardiology. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par European Society of Cardiology ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
Cardiology This Week: A concise summary of recent studies
LAA occlusion
Chronic thromboembolic pulmonary hypertension
Mythbusters: Do cholesterol lowering drugs provoke dementia?
Host: Perry Elliott
Guests: Carlos Aguiar, Stephan Rosenkranz, Jacqueline Saw
Want to watch that episode? Go to: https://esc365.escardio.org/event/1140
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.
Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.
Stephan Rosenkranz has declared to have potential conflicts of interest to report: speaker fees and consultation for Bayer, MSD, Boehringer-Ingelheim and Inari.
Jacqueline Saw has declared to have potential conflicts of interest to report: proctor and consultancy fees from Abbott and Boston Scientific.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
42 episodes
Partager
